[1] Bauriedel G, Hutter R, Welsch U, et al. Role of smooth muscle cell death in advanced coronary primary lesions: implications for plaque instobility[J]. Cardiovasc Res, 1999, 41(2): 480-488.
[2] 苏应瑞, 查金顺, 许朝祥, 等.阻塞性睡眠呼吸暂停低通气综合症伴冠心病:血清高半胱氨酸和C-反应蛋白水平及临床意义[J].国际放射医学核医学杂志, 2011, 35(5): 275-278.
[3] Wu CK, Tseng CD, Huang YT, et al. AngiotensinⅡ does not influence expression of sureplasmic reticulum Ca2+ ATpase in atrial myocytes[J]. J Renin Angiotension Aldosterone Syst, 2009, 10(3): 121-126.
[4] Ruster C, Wolf G. Renin-angiotension-aldosterone system and progression of renal disease[J]. J Am Soc Nephrol, 2006, 17(11): 2985-2991.
[5] Zukowska Z, Granl DS, Lee FW. Neuropeptide Y: a noval mechanism for ischemic angioenesis[J]. Trends Cardiovasc Med, 2003, 13(2): 86-92.
[6] Ekstrand AJ, Gao R, Bjorndahl M, et al. Deletion of neuropeptide Y(NPY)2 receptor in mice results in blockage of NPY-induced angiogenesis and delayed wound healing[J]. Proc Natl Acad Sci USA, 2003, 100(10): 6033-6042.
[7] 陆永怡, 陈群, 杨永青.原发性高血压、AngⅡ分型和IGF-1水平的测定[J].国际放射医学核医学杂志, 2010, 34(5): 294-296.
[8] Monteiro CM, Pinheiro LF, Izar MC, et al. Highly sensitive C-reactive protein and male gender are independently related to the severity of coronary disease in patients with metabolic syndrome and a acute coronary event[J]. Braz J Med Biol Res, 2010, 43(3): 297-302.
[9] Nishida H, Horio T, Suzuki Y, et al. Interleukin-6 as an independent predictor of future cardiovascular events in high-risk Japanese patients: comparison with C-reactive protein[J]. Cytokine, 2011, 53(3): 342-346.